A 28-year-old woman with a history of intravenous drug use presents with acute hepatitis (ALT 3200 U/L, AST 2800 U/L). She is anti-HBc positive and HBsAg negative. HBeAg is negative. Which investigation is most appropriate to determine if this is acute hepatitis B infection versus chronic hepatitis B with acute exacerbation?

Explanation

## Diagnosis of Acute vs. Chronic Hepatitis B ### Clinical Context The patient is anti-HBc positive and HBsAg negative with acute hepatitis. This serological pattern is seen in: 1. **Acute hepatitis B** (anti-HBc IgM positive, anti-HBc IgG negative) 2. **Chronic hepatitis B with acute exacerbation** (anti-HBc IgG positive, anti-HBc IgM negative) 3. **Occult hepatitis B** (HBsAg negative but HBV DNA positive) The key discriminator is the IgM fraction of anti-HBc. ### Why Anti-HBc IgM is the Investigation of Choice **Key Point:** Anti-HBc IgM is the most specific marker for acute hepatitis B infection and reliably distinguishes acute infection from chronic disease with exacerbation. **High-Yield:** Anti-HBc IgM: - Appears early in acute HBV infection (coincides with HBsAg appearance) - Remains detectable for 6 months in acute infection - Is **absent or very low** in chronic hepatitis B, even during exacerbations - Is the gold standard for confirming acute HBV infection ### Serological Interpretation in HBV Infection | Marker | Acute HBV | Chronic HBV | Chronic + Exacerbation | Occult HBV | |--------|-----------|-------------|------------------------|-------------| | **HBsAg** | + | + | + | − | | **Anti-HBc IgM** | **+ (high)** | − | − | − | | **Anti-HBc IgG** | − (appears later) | + | + | + | | **HBeAg** | Often + | Variable | Often + | − | | **Anti-HBe** | − | Variable | Variable | − | | **HBV DNA** | High | Variable | High | Low/detectable | **Clinical Pearl:** The presence of anti-HBc IgM in a patient with acute hepatitis and anti-HBc positivity virtually confirms acute HBV infection rather than exacerbation of chronic disease. ### Why Other Tests Are Not Diagnostic **HBV DNA by PCR:** Although detectable in both acute and chronic HBV, it does not distinguish between acute infection and chronic disease with exacerbation. Both can have high HBV DNA levels during acute flares. **Anti-HBs antibody:** This appears late (after HBsAg clearance) and indicates recovery or immunity. It is not present during acute infection and is not useful for this clinical scenario. **Hepatitis B core antigen (HBcAg) in serum:** HBcAg is not routinely detected in serum; it is found in hepatocyte nuclei. This is not a standard diagnostic test for acute vs. chronic HBV. ### Algorithm for HBsAg-Negative, Anti-HBc-Positive Patients ```mermaid flowchart TD A[Anti-HBc positive, HBsAg negative<br/>Acute hepatitis]:::outcome --> B{Anti-HBc IgM?}:::decision B -->|Positive/High| C[Acute Hepatitis B]:::outcome B -->|Negative/Low| D[Chronic HBV or Occult HBV]:::outcome D --> E{HBV DNA detectable?}:::decision E -->|Yes| F[Occult Hepatitis B]:::outcome E -->|No| G[Resolved HBV<br/>or False positive anti-HBc]:::outcome ``` [cite:Harrison 21e Ch 297]